AFP Washington, United States ● Thu, January 20, 2022 2022-01-20 09:28 0 22dc95a23fb944820adae5904f11d523 2 Americas vaccine,US,Delta-variant,immunity,CDC Free During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived COVID were better protected than those who were vaccinated and not previously infected, a new study said Wednesday. The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC). The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people. Indeed, by November 30, 2021, some 131,000 residents of California and New York … [Read more...] about Natural immunity more potent than vaccines during US Delta wave: study
Vaccinated delta variant israel
Suganuma (left) and Cheng showing the media the capabilities of nanoe technology - A + A KUALA LUMPUR (Jan 20): The exclusive nano-sized atomised water particles generating technology — nanoe technology — by Panasonic has proven its inhibitory effects against four novel coronavirus variants (SARS-CoV-1), namely Alpha, Beta, Gamma and Delta. It also improves indoor air quality. In a media briefing on Thursday (Jan 20), Managing Director of Panasonic Corp’s QAFL Business Promotion Office, Ichiro Suganuma said that although the virus inhibitory test on the latest Omicron variant has not been carried out yet, based on the previous record, the nanoe technology should be able to inhibit that variant too. “Panasonic has been conducting research on this [nanoe] technology since 1997 and has realised its effectiveness in a variety of areas, including inhibiting pathogenic microorganisms (bacteria, fungi, and viruses) and allergens, breaking down PM 2.5 components that … [Read more...] about Panasonic’s nanoe technology inhibits Covid-19 variants; improves indoor air quality
- A + A BERLIN (Jan 20): The German police are investigating 12,000 suspected bogus vaccination certificates in the country, Anadolu Agency quoted local media on Wednesday (Jan 19). An investigation has been launched after fraud related to the 3G (vaccination, testing, and recovery) requirement increased in many areas with 12,000 vaccination certificates forged in various states, according to the German News Agency. It was stated that fraud is widespread on the messaging application Telegram and these certificates can be obtained for 200-300 euros (RM951-RM1,427). It is not possible for the law enforcement agencies to determine the actual number of fake vaccine documents in circulation at the moment, the agency said. The contract of Markus Anfang, the coach of Werder Bremen, a German second football league team, was terminated and an investigation was launched after it was revealed that he had used a fake vaccination certificate. The German government has … [Read more...] about German cops investigating 12,000 fake vaccine certificates
- A + A TAIPEI (Jan 20): Taiwan will mandate the use of passes that provide proof of Covid-19 vaccination for entry into entertainment venues, the government said on Thursday, as it seeks to reduce infection risks while tackling a small rise in domestic Omicron cases. The Central Epidemic Command Centre said that from Friday entry into venues including bars and nightclubs would require proof of full vaccination, either by showing a physical vaccine card or a new digital card. The centre said the move was needed to minimise the risk of community transmission as Taiwan deals with a small number of domestic infections of the Omicron variant. More than 70% of people in Taiwan have received two vaccine doses and booster shots are currently being rolled out, though only around 10% of residents have had their third shot so far. Taiwan has kept the pandemic well under control thanks to strict border measures enacted early on and a highly efficient tracing system. It … [Read more...] about Taiwan to mandate Covid-19 vaccination proof for entertainment venues
- A + A KUALA LUMPUR (Jan 20): Manulife Investment Management (Manulife IM) says Malaysia’s accelerated vaccination rates, which was faster than what the market had anticipated, combined with increased government spending ahead of the next general election could support domestic demand amid the lingering effects of the pandemic. At a media briefing on Thursday (Jan 20), Manulife IM’s Head of Macro Strategy (Asia), Sue Trinh said the outlook for Asian countries in 2022 is a mixed bag as the cyclical macro conditions are favourable for reopening and recovery in Taiwan, select Asean countries such as Vietnam, Indonesia, Thailand, Singapore and Malaysia, as well as Japan. “Structurally, the Asian region has a lot of work to do to recoup lost output due to the pandemic. The biggest concern remains weak consumer demand which will be exposed by the looming downturn in export growth. “On the other hand, Asia’s milder inflation expectation comes down to one simple factor — … [Read more...] about Accelerated vaccination rates, higher govt spending to support domestic demand, says Manulife IM
- A + A JAKARTA (Jan 20): Indonesia's central bank announced on Thursday a surprise 300 basis point hike in the reserve requirement ratio (RRR) for banks over the next eight months, in one of its first concrete signs of monetary tightening. At its first policy meeting of the year, Bank Indonesia (BI) kept its benchmark seven-day reverse repurchase rate steady at 3.50%, as expected. It also left two other main policy rates unchanged. But in a sign that BI has a keen eye on the US Federal Reserve's anticipated tightening and potential jolts to Indonesian financial markets, Governor Perry Warjiyo announced three RRR hikes, starting with 150 basis points in March, 100 bps from June and another 50 bps from September to contain liquidity. All 30 economists polled by Reuters poll had expected BI to stand pat on rates throughout the first half of 2022 and raise them in the third quarter, even though the Fed looks likely to start raising interest rates as soon as March. … [Read more...] about Indonesia’s central bank surprises with hefty RRR hikes, eyes Fed
Tweaks for the revised Test & Go will be debated by the CCSA and hopefully announced today. A few leaks indicate that the Test & Go program will, indeed, be re-introduced but there will be tightening of aspects of the program. If the rumours are true, arrivals will undergo two PCR tests during their initial seven days, the first when travellers arrive and the second on the fifth or sixth day. The Public Health Ministry also suggested yesterday that overseas visitors will have to take out comprehensive health insurance that covers all Covid-19 contingencies. The Ministry’s permanent secretary announced yesterday that visitors must ensure they are fully covered for all types of Covid-19 treatments. The hot tip for a reboot of the Test & Go program, which only requires a single night stay in an SHA+ hotel whilst waiting for your arrival test results, is for the start of February. The Thaiger will bring you all the details and latest decisions from the CCSA meeting as … [Read more...] about Thailand News Update | Tweaks for the revised Test & Go announced today!
- A + A KUALA LUMPUR (Jan 20): Bank Negara Malaysia (BNM) maintained its overnight policy rate (OPR) at 1.75% in its first monetary policy committee (MPC) meeting for the year. The central bank in a statement on Thursday (Jan 20) said the MPC considers the current stance of monetary policy to be appropriate and accommodative. "Fiscal and financial measures will continue to cushion the economic impact on businesses and households and provide support to economic activity. "The stance of monetary policy will continue to be determined by new data and their implications on the overall outlook for inflation and domestic growth," it elaborated. BNM added that headline inflation averaged 2.3% for the period of January-November last year and expected average headline inflation in 2022 to remain moderate as the base effect from fuel inflation dissipates. Meanwhile, underlying inflation as measured by core inflation is expected to edge upwards as economic activity … [Read more...] about BNM maintains OPR at 1.75% in first MPC meeting for 2022
Every major U.S. stock index has taken a step backward since the start of December. U.S. equities have reversed course this month because of inflationary pressures, the omicron variant, and year-end tax-loss harvesting. What's the best strategy to navigate this chaotic market? Dividend stocks are always worth owning as part of a well-rounded portfolio. Equities that dole out regular dividends to shareholders, after all, can smooth out the rough patches during volatile periods in the market. What's more, these types of stocks come with a built-in level of safety because of their attractiveness as passive income vehicles. Which dividend stocks are must-owns right now? The top pharma stocks Amgen ( NASDAQ:AMGN ) , Bristol Myers Squibb ( NYSE:BMY ) , and GlaxoSmithKline ( NYSE:GSK ) are all worth adding to your portfolio soon. Here's a look at the key features associated with each of these three rock-solid dividend plays . Image source: Getty Images. 1. … [Read more...] about 3 Must-Own Dividend Stocks in This Chaotic Market
The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate. Not every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason. 1. Amgen Biotech company Amgen ( NASDAQ:AMGN ) has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more. Image source: Getty Images. When a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A … [Read more...] about Is It Time to Buy the Dow’s 3 Worst Performing Stocks This Year?